There is or is going to be an article in the Early Edition of the Proceedings of the National Academies of Science talking about a study in which adult stem cells, which pose no ethical problems, were used to cure type 2 diabetes in mice.[1] This is the sort of thing that ought to be incredibly news worthy. It will be under-reported, however, because of the focus on embryonic stem cells.

  1. United Press International, Inc. “Adult stem cells show promise for diabetes” www.upi.com 2006-11-07. http://www.upi.com/HealthBusiness/view.php?StoryID=20061107-054717-9089r